Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in Intellia Therapeutics Inc
Today
Create an eToro account to buy NTLA stock on a secure, user-friendly, multi-asset trading platform.
Buy Intellia Therapeutics Inc
NTLA Price
Intellia Therapeutics Inc NTLA
Buy NTLA

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Intellia Therapeutics Inc News

NTLA Price

Intellia Therapeutics Inc NTLA

$15.190.48(3.26%)(1D)

NTLA Stock Price Chart

-8.76%
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Intellia Therapeutics Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Intellia Therapeutics Inc share price today is $15.19, reflecting a 3.26% change over the last 24 hours and 16.02% over the past week. The current market capitalization of NTLA is 1.55B with an average volume in the last three months of 2.31M. The stock has a P/E ratio of -2.79 and a dividend yield of 0%. With the stock’s beta sitting at 2.1
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$1.55B
Day’s Range
i
Shows the high and low prices of the day.
12.8 - 17.77
52W Range
i
Shows the high and low prices of the last year.
12.8 - 47.14
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
2.31M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-2.79
Revenue
i
The total income generated by this company’s goods and services last year.
$43.09M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$15.21
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-5.45
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
2.1
About Intellia Therapeutics Inc
Intellia Therapeutics Inc. is an American clinical-stage biotechnology company with a focus on gene editing and the development of therapeutics based on a unique biological gene editing tool called CRISPR, a technology for genome editing, which is the process of altering selected sequences of genomic deoxyribonucleic acid (DNA). The company is engaged in developing products aimed at helping patients suffering from various medical conditions, such as cancer, genetic disorders, viral infections and inflammatory disorders. The company was founded in 2014 and is headquartered in Cambridge, Massachusetts.

The firm is engaged in both in vivo programs, which use intravenously administered CRISPR as therapy, enabling precise editing of disease-causing genes directly within specific target tissues, and ex vivo programs, which use CRISPR to create new therapies using engineered human cells, which can then be administered to treat cancer and autoimmune diseases.

Each treatment consists of a particle specifically designed to deliver to the liver a simple, two-part genome editing system: the messenger RNA that encodes the Cas9 protein and guides RNA to the target gene. The firm’s stock is traded on the NASDAQ where it is listed under the stock ticker NTLA.

Track the NTLA price chart by adding this stock to your eToro virtual portfolio today.
Buy NTLA

How can I buy Intellia Therapeutics Inc stocks?

To purchase Intellia Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Intellia Therapeutics Inc (NTLA) page and place an order to buy Intellia Therapeutics Inc.
Buy NTLA
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2024
Top Dividend Stocks for 2024
In times of market volatility, dividend investing provides investors with a steady source of income. eToro presents the top 6 dividend stocks to consider.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2024
AI Stocks Poised for Growth in 2024
Gear up for 2024 with a focus on AI stocks. Dive into the promising growth of C3.ai, Palantir Technologies, CrowdStrike, through eToro's expert analysis.
Read More
Go to the Academy >
Graph
Buy Intellia Therapeutics Inc
Invest in Intellia Therapeutics Inc
Today
Create an eToro account to buy NTLA stock on a secure, user-friendly, multi-asset trading platform.
Buy NTLA

FAQ

The current price of NTLA is $15.19.
The average price target for Intellia Therapeutics Inc is $15.19. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Intellia Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Intellia Therapeutics Inc is $1.55B
Select the "1D" or "1W" timeframe on the eToro chart and zoom out to see the historical price movements of Intellia Therapeutics Inc. The price of Intellia Therapeutics Inc has ranged between 12.8 and 47.14 over the last year.
To buy NTLA, visit the "Intellia Therapeutics Inc (NTLA)" page. Once you have created an account and deposited funds, click the "Trade" button and decide how much Intellia Therapeutics Inc you want to purchase. You can also place an order that will buy NTLA at a specific price in the future.
Daily Movers
Today's biggest gainers and losers.
Buy NTLA
Scroll to top